EUVIMEDEUVIMED entdecken
Crossref

Unlocking the antiviral arsenal: Computational exploration of Langya virus (L, C, V, W) through phylogenetic analysis and molecular modeling

Venu Paritala, Sukesh Kalva, Rajashekhar Reddy Shagamreddy

American Journal of Biopharmacy and Pharmaceutical Sciences · 2024

DOI: 10.25259/ajbps_13_2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Biopharmacy and Pharmaceutical Sciences, 2024. Verfasst von Venu Paritala und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In response to the ongoing COVID-19 pandemic and the resurgence of the Langya virus (LayV) in Eastern China, there is an urgent need for novel antiviral treatments. Given the limited research available on LayV, this study aimed to explore its evolutionary relationships and construct accurate three-dimensional (3D) models of key viral proteins, which are essential for understanding the virus’s mechanisms and vulnerabilities. Materials and Methods: Computational approaches were employed to examine the evolutionary relationships of LayV using Molecular Evolutionary Genetics Analysis (MEGA). To build reliable 3D protein structures of the viral proteins C, L, W, and V, SwissModel and Faster AlphaFold (AF) were utilised. Model validation was conducted in PROCHECK, PROSA, Errat, Verify 3D, and Prove. Additionally, binding site analysis was carried out using various platforms such as Computed Atlas of Surface Topography of Proteins (CASTp), PHYRE2, PrankWeb, and SCFBio to ensure the robust identification of key interaction sites.

Results

The phylogenetic analysis revealed that LayV is closely related to the Henipavirus genus. The structural models generated through SwissModel for the C, L, and W proteins showed high accuracy, with 93.2%, 89.4%, and 87.5% of residues residing in favoured regions, respectively. The AF model of the V protein exhibited optimal structural validation, with 82.0% of residues in favoured regions. Binding site analysis identified key interaction regions essential for targeted drug design.

Conclusion

This comprehensive study highlighted the close evolutionary relationship between LayV and Henipaviruses and validated the structural models of key LayV proteins, offering a foundation for future antiviral drug design. The robust computational analysis and structural modelling provide a critical framework for selective drug development, contributing to the strategic fight against LayV.

Zitieren

APA

Paritala, V., Kalva, S., & Shagamreddy, R. R. (2024). Unlocking the antiviral arsenal: Computational exploration of Langya virus (L, C, V, W) through phylogenetic analysis and molecular modeling. American Journal of Biopharmacy and Pharmaceutical Sciences. https://doi.org/10.25259/ajbps_13_2024

Vancouver

Paritala V, Kalva S, Shagamreddy RR. Unlocking the antiviral arsenal: Computational exploration of Langya virus (L, C, V, W) through phylogenetic analysis and molecular modeling. American Journal of Biopharmacy and Pharmaceutical Sciences. 2024. doi:10.25259/ajbps_13_2024

BibTeX
@article{Paritala2024,
  author = {Paritala, Venu and Kalva, Sukesh and Shagamreddy, Rajashekhar Reddy},
  title = {Unlocking the antiviral arsenal: Computational exploration of Langya virus (L, C, V, W) through phylogenetic analysis and molecular modeling},
  journal = {American Journal of Biopharmacy and Pharmaceutical Sciences},
  year = {2024},
  doi = {10.25259/ajbps_13_2024}
}
Kostenlos starten →